CGEM 12.58 (-3.97%)
US2300311063BiotechnologyBiotechnology

Cullinan Oncology (CGEM) Stock Highlights

12.58 | -3.97%
2024-11-21 03:56:28
Cullinan Oncology Inc is a biopharmaceutical company. It is focused on developing a diversified pipeline of targeted oncology and immuno-oncology therapies with transformative potential for cancer patients.

Statistics

Range Today
12.5 13.52
Volume Today 854.7K
Range 1 Year
7.64 30.19
Volume 1 Year 152.59M
Range 3 Year
7.3 30.19
Volume 3 Year 281.83M
Range 10 Year
7.3 59.85
Volume 10 Year 340.36M

Highlights

Market Capitalization 932.81M (small)
Floating Shares 38.52M
Current Price 12.58
Price To Earnings -5.18
Price To Book 1.49
Earnings Per Share -3.06
Payout Ratio 0%

Performance

Latest -3.97%
1 Month -24.76%
3 Months -28.97%
6 Months -45.71%
1 Year +41.83%
3 Years -35.49%
5 Years -70.05%
10 Years -70.05%

Benchmarks


Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.